R.M. Davis Inc’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,170
Closed -$284K 229
2017
Q2
$284K Sell
1,170
-2
-0.2% -$470 0.01% 185
2017
Q1
$280K Sell
1,172
-1,029
-47% -$240K 0.01% 189
2016
Q4
$462K Sell
2,201
-403
-15% -$83.5K 0.02% 158
2016
Q3
$600K Buy
2,604
+160
+7% +$39.1K 0.03% 143
2016
Q2
$565K Buy
2,444
+290
+13% +$66.9K 0.03% 146
2016
Q1
$577K Buy
2,154
+223
+12% +$63.8K 0.03% 138
2015
Q4
$603K Sell
1,931
-56
-3% -$16.7K 0.03% 134
2015
Q3
$540K Buy
1,987
+392
+25% +$120K 0.03% 142
2015
Q2
$484K Sell
1,595
-1,076
-40% -$321K 0.03% 144
2015
Q1
$795K Buy
+2,671
New +$762K 0.04% 124

Other funds holding AGN

R.M. Davis Inc's AGN Position: Q3 2017 in Review

R.M. Davis Inc sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 1,170 shares — an estimated $284K sold.

R.M. Davis Inc first reported a position in AGN in Q1 2015 and held it in 10 quarters. The position peaked at $795K in Q1 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • R.M. Davis Inc reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • R.M. Davis Inc sold 1,170 Allergan plc shares in Q3 2017, an estimated $284K.
  • R.M. Davis Inc first reported a position in Allergan plc in Q1 2015 and held it in 10 quarters.
  • R.M. Davis Inc's Allergan plc position peaked at $795K in Q1 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on R.M. Davis Inc's 13F filing for Q3 2017, filed 24 Oct 2017.